ABVC BioPharma, Inc. (ABVC) Stock Overview
Explore ABVC BioPharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ABVC BioPharma, Inc. (ABVC)
Key Financials
Key Financials
Market Cap
18.7M
P/E Ratio
-3.57
EPS (TTM)
$-0.39
ROE
-0.92%
ABVC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ABVC BioPharma, Inc. (ABVC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.57 and a market capitalization of 18.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.